Mephedrone (4-methylmethcathinone) supports intravenous self-administration in Sprague-Dawley and Wistar rats.
about
Legal highs: staying on top of the flood of novel psychoactive substancesBinge-like acquisition of 3,4-methylenedioxypyrovalerone (MDPV) self-administration and wheel activity in ratsThe preclinical pharmacology of mephedrone; not just MDMA by another name.Intravenous self-administration of entactogen-class stimulants in male ratsNeuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related AnalogsUse of synthetic cathinones and cannabimimetics among injection drug users in San Diego, CaliforniaCocaine self-administration in social dyads using custom-built operant conditioning chambersPredicting abuse potential of stimulants and other dopaminergic drugs: overview and recommendationsSynthetic cathinones and their rewarding and reinforcing effects in rodents.Behavioral pharmacology of designer cathinones: a review of the preclinical literature3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.The new stimulant designer compound pentedrone exhibits rewarding properties and affects dopaminergic activity.Baths salts, spice, and related designer drugs: the science behind the headlines.The new psychoactive substances 5-(2-aminopropyl)indole (5-IT) and 6-(2-aminopropyl)indole (6-IT) interact with monoamine transporters in brain tissue.Abuse-related neurochemical and behavioral effects of cathinone and 4-methylcathinone stereoisomers in ratsNeurotoxicity Induced by Mephedrone: An up-to-date Review.Mephedrone interactions with cocaine: prior exposure to the 'bath salt' constituent enhances cocaine-induced locomotor activation in rats.Intravenous self-administration of mephedrone, methylone and MDMA in female rats.Discriminative-stimulus effects of second generation synthetic cathinones in methamphetamine-trained ratsMephedrone alters basal ganglia and limbic dynorphin systems.One day access to a running wheel reduces self-administration of D-methamphetamine, MDMA and methylone.Effects of active anti-methamphetamine vaccination on intravenous self-administration in rats.In vivo potency and efficacy of the novel cathinone α-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male ratsDifferential effects of 3,4-methylenedioxypyrovalerone (MDPV) and 4-methylmethcathinone (mephedrone) in rats trained to discriminate MDMA or a d-amphetamine + MDMA mixture.The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats.Abuse-related and abuse-limiting effects of methcathinone and the synthetic "bath salts" cathinone analogs methylenedioxypyrovalerone (MDPV), methylone and mephedrone on intracranial self-stimulation in rats.Bath salts and synthetic cathinones: an emerging designer drug phenomenon.Neuronal extracellular signal-regulated kinase (ERK) activity as marker and mediator of alcohol and opioid dependence.Khat and synthetic cathinones: a review.Reinforcing Effects of Cathinone NPS in the Intravenous Drug Self-Administration Paradigm.Neurotoxicology of Synthetic Cathinone Analogs.Predicting the Abuse Liability of Entactogen-Class, New and Emerging Psychoactive Substances via Preclinical Models of Drug Self-administration.Clinical Pharmacology of the Synthetic Cathinone Mephedrone.Mephedrone, methylone and 3,4-methylenedioxypyrovalerone (MDPV) induce conditioned place preference in mice.Pharmacology should be at the centre of all preclinical and clinical studies on new psychoactive substances (recreational drugs).Patterns of use and toxicity of new para-halogenated substituted cathinones: 4-CMC (clephedrone), 4-CEC (4-chloroethcatinone) and 4-BMC (brephedrone).'Second-generation' mephedrone analogs, 4-MEC and 4-MePPP, differentially affect monoamine transporter function.Locomotor Stimulant and Rewarding Effects of Inhaling Methamphetamine, MDPV, and Mephedrone via Electronic Cigarette-Type Technology.Is there any difference in patterns of use and psychiatric symptom status between injectors and non-injectors of mephedrone?Inhaled delivery of Δ(9)-tetrahydrocannabinol (THC) to rats by e-cigarette vapor technology.
P2860
Q26799231-EAE9803B-9F0C-4AEE-8C14-E9512886771FQ27324932-D6289B05-7FD2-4F79-A227-CAC25D8EE4A3Q30412911-8A15A46F-638A-4A1B-A833-C4AEF7E6EA46Q30680394-0D27DB01-24A1-4C7D-AE7B-ED97FAB7E985Q33566201-D68F3A05-E598-4994-81B6-7EEBDCB0B5F1Q33968846-5AB63966-2F2B-4A19-BCA1-3B2793518F12Q34216347-A0ABF4C4-2FA4-4DDB-B301-3C5F7B3D7AADQ34225896-17D898E1-82E9-4A07-9671-263327CE9BFBQ34352354-530F4DBC-5134-4C5D-8F0C-FADDECE0CA09Q34385074-79433877-2BAD-43E0-90EA-95ED403360DEQ34459984-0FAAF6F2-6D40-4603-AA29-29242BF29319Q34490243-14AE8B34-870A-4982-BDB8-7DA7FE3373CDQ34491601-4C404EFB-74CE-47FC-9A98-B4F399D144B7Q34493739-AA350EB1-DC35-4B35-BA17-5F467A703810Q34507647-F5D2ABCB-A18C-4700-9171-D1AFC80611E4Q34546425-8CE3935D-58EE-4C70-81A4-B8382B0FDED1Q34941985-ACD69391-E166-4A40-8B01-B34333AE2422Q35137747-CAFF8D9B-9296-4006-A931-8F6DD4C0288EQ35181608-BF5EA767-510B-4B05-B860-72053EA2EF24Q35186200-82955EA9-65A3-4053-859E-EC8DCA8086D7Q35661177-556558A5-C71D-438F-9D9F-DBC130AC5279Q35875875-19CAB67D-E983-4234-80EA-64047C8E076AQ35889508-10CA8312-39E9-4164-BDD1-623E1CD39DA4Q36510321-266CF298-59D9-476D-B647-D37D0B6095EFQ36926811-22AD1014-50AC-4414-B4AB-FD3B0A37A22DQ37424592-2972C808-974E-458E-82B1-148FD52995E1Q37540813-3E6B2CBB-E6A1-4AAA-B51A-F04B722C074DQ37629743-A95B38AD-B5EA-42CE-9C8B-330CCC7A552EQ38169542-0076C17D-3096-48FC-BF3A-1BD4ED290AA3Q38840376-27097E8E-82AB-4CAF-9474-3A93B6D1DDB1Q38983638-4E7C4C1E-E1A2-4EE0-9D57-573F5C9F0EF7Q39026719-F485064B-9C87-40CB-8F13-D77F81223494Q39052269-39B12B04-FF57-4288-A1CC-823AC707E993Q39208665-BBC15982-A46A-496F-916A-89B64AD68B93Q39221467-C5A926FE-96B7-4C13-8823-7AC6C63BB57EQ39402042-628B722C-8A40-4345-80B5-13E214B53F20Q39644366-E8A38D4F-55F5-409B-A80B-30AE509544C7Q39699950-41A84F7D-5CED-4FA0-821E-3162412F7DC5Q40300253-D1DD5D26-0403-42B2-9CD4-0708CB8350CCQ41654668-24F6551D-7651-418C-B432-A81F521BF189
P2860
Mephedrone (4-methylmethcathinone) supports intravenous self-administration in Sprague-Dawley and Wistar rats.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Mephedrone (4-methylmethcathin ...... prague-Dawley and Wistar rats.
@ast
Mephedrone (4-methylmethcathin ...... prague-Dawley and Wistar rats.
@en
type
label
Mephedrone (4-methylmethcathin ...... prague-Dawley and Wistar rats.
@ast
Mephedrone (4-methylmethcathin ...... prague-Dawley and Wistar rats.
@en
prefLabel
Mephedrone (4-methylmethcathin ...... prague-Dawley and Wistar rats.
@ast
Mephedrone (4-methylmethcathin ...... prague-Dawley and Wistar rats.
@en
P2093
P2860
P356
P1433
P1476
Mephedrone (4-methylmethcathin ...... prague-Dawley and Wistar rats.
@en
P2093
Deborah J Barlow
Deepshikha Angrish
Karen L Houseknecht
Kevin M Creehan
M Jerry Wright
Michael A Taffe
Shawn M Aarde
Sophia A Vandewater
Tobin J Dickerson
P2860
P304
P356
10.1111/ADB.12038
P577
2013-01-30T00:00:00Z